This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jaboin, J. Articles by Thiele, C. J. Search for Related Content PubMed PubMed Citation Articles by Jaboin, J. Articles by Thiele, C. J.

Brain-derived Neurotrophic Factor Activation of TrkB Protects Neuroblastoma Cells from Chemotherapy-induced Apoptosis via Phosphatidylinositol 3'-Kinase Pathway

Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892 [J. J., C. J. T.]; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea 100-799 [C. J. K.]; and Brain Tumor Research Centre, Montreal Neurological Institute, Montreal, Quebec, Canada, H3A 2B4 [D. R. K.]

Neuroblastoma (NB) tumors expressing high levels of brain-derived neurotrophic factor (BDNF) and TrkB are associated with poor 5-year survival outcomes. Our previous studies indicated that BDNF blocked the cytotoxic effects of vinblastine on NB cells. Here we evaluated the ability of BDNF to decrease the chemosensitivity of NB cells to a number of common chemotherapeutic agents. Two SH-SY5Y NB cell lines (TB3 and TB8) expressing TrkB under the control of a tetracycline (Tet)-repressible promoter element were generated, and used to assess apoptosis resulting from treatment with cisplatin, doxorubicin, etoposide, and vinblastine. BDNF treatment of high TrkB-expressing TB8 (Tet-) and TB3 (Tet-) cells blocked drug-induced cell death in a dose-dependent manner. Only high-dose BDNF (100 ng/ml) could block the effects of chemotherapy in low TrkB-expressing cells. The ability of BDNF to rescue the cells from chemotherapeutic agent-induced cell death was inhibited by treatment with the Trk tyrosine kinase inhibitor K252a or the phosphatidylinositol 3'-kinase (PI3K) inhibitor LY294002, but not by the mitogen-activated protein kinase kinase inhibitor PD98059 or the peritoneal lymphocyte inhibitor U73122, indicating that both TrkB and PI3K activities are required for the survival-promoting effects of BDNF. BDNF also protected TrkB-expressing NGP and KCNR NB cells from chemotherapeutic agent-induced cell death, and LY294002 inhibited this protection. These results suggest that TrkB and BDNF can contribute to the chemoresistance of poor prognosis tumors, and that suppression of PI3K activity might improve the ability of these agents to induce the death of NB tumors.

This article has been cited by other articles:

				B. Gabriele and T. Enrico BDNF splice variants from the second promoter cluster support cell survival of differentiated neuroblastoma upon cytotoxic stress J. Cell Sci., January 1, 2009; 122(1): 36 - 43. [Abstract] [Full Text] [PDF]

				D. Boller, A. Schramm, K. T. Doepfner, T. Shalaby, A. O. von Bueren, A. Eggert, M. A. Grotzer, and A. Arcaro Targeting the Phosphoinositide 3-Kinase Isoform p110{delta} Impairs Growth and Survival in Neuroblastoma Cells Clin. Cancer Res., February 15, 2008; 14(4): 1172 - 1181. [Abstract] [Full Text] [PDF]

				Z. Li, F. Tan, and C. J. Thiele Inactivation of glycogen synthase kinase-3 contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells Mol. Cancer Ther., December 1, 2007; 6(12): 3113 - 3121. [Abstract] [Full Text] [PDF]

				L. K. Martens, K. M. Kirschner, C. Warnecke, and H. Scholz Hypoxia-inducible Factor-1 (HIF-1) Is a Transcriptional Activator of the TrkB Neurotrophin Receptor Gene J. Biol. Chem., May 11, 2007; 282(19): 14379 - 14388. [Abstract] [Full Text] [PDF]

				D. Opel, C. Poremba, T. Simon, K.-M. Debatin, and S. Fulda Activation of Akt Predicts Poor Outcome in Neuroblastoma Cancer Res., January 15, 2007; 67(2): 735 - 745. [Abstract] [Full Text] [PDF]

				A. M. Monjazeb, K. P. High, A. Connoy, L. S. Hart, C. Koumenis, and F. H. Chilton Arachidonic acid-induced gene expression in colon cancer cells Carcinogenesis, October 1, 2006; 27(10): 1950 - 1960. [Abstract] [Full Text] [PDF]

				K. Nakamura, K. C. Martin, J. K. Jackson, K. Beppu, C.-W. Woo, and C. J. Thiele Brain-Derived Neurotrophic Factor Activation of TrkB Induces Vascular Endothelial Growth Factor Expression via Hypoxia-Inducible Factor-1{alpha} in Neuroblastoma Cells. Cancer Res., April 15, 2006; 66(8): 4249 - 4255. [Abstract] [Full Text] [PDF]

				M. Hecht, J. H. Schulte, A. Eggert, J. Wilting, and L. Schweigerer The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness Carcinogenesis, December 1, 2005; 26(12): 2105 - 2115. [Abstract] [Full Text] [PDF]

				T. R. Geiger and D. S. Peeper The Neurotrophic Receptor TrkB in Anoikis Resistance and Metastasis: A Perspective Cancer Res., August 15, 2005; 65(16): 7033 - 7036. [Abstract] [Full Text] [PDF]

				J.-F. Lavoie, L. LeSauteur, J. Kohn, J. Wong, O. Furtoss, C. J. Thiele, F. D. Miller, and D. R. Kaplan TrkA Induces Apoptosis of Neuroblastoma Cells and Does So via a p53-dependent Mechanism J. Biol. Chem., August 12, 2005; 280(32): 29199 - 29207. [Abstract] [Full Text] [PDF]

				T. Dobson, A. Minic, K. Nielsen, E. Amiott, and L. Krushel Internal initiation of translation of the TrkB mRNA is mediated by multiple regions within the 5' leader Nucleic Acids Res., May 20, 2005; 33(9): 2929 - 2941. [Abstract] [Full Text] [PDF]

				E. Terui, T. Matsunaga, H. Yoshida, K. Kouchi, H. Kuroda, T. Hishiki, T. Saito, S.-i. Yamada, H. Shirasawa, and N. Ohnuma Shc Family Expression in Neuroblastoma: High Expression of shcC Is Associated with a Poor Prognosis in Advanced Neuroblastoma Clin. Cancer Res., May 1, 2005; 11(9): 3280 - 3287. [Abstract] [Full Text] [PDF]

				Z. Li, J. Jaboin, P. A. Dennis, and C. J. Thiele Genetic and Pharmacologic Identification of Akt as a Mediator of Brain-Derived Neurotrophic Factor/TrkB Rescue of Neuroblastoma Cells from Chemotherapy-Induced Cell Death Cancer Res., March 15, 2005; 65(6): 2070 - 2075. [Abstract] [Full Text] [PDF]

				G. M. Sclabas, S. Fujioka, C. Schmidt, Z. Li, W. A.I. Frederick, W. Yang, K. Yokoi, D. B. Evans, J. L. Abbruzzese, K. R. Hess, et al. Overexpression of Tropomysin-Related Kinase B in Metastatic Human Pancreatic Cancer Cells Clin. Cancer Res., January 15, 2005; 11(2): 440 - 449. [Abstract] [Full Text] [PDF]

				Y. Liu, M. Encinas, J. X. Comella, M. Aldea, and C. Gallego Basic Helix-Loop-Helix Proteins Bind to TrkB and p21Cip1 Promoters Linking Differentiation and Cell Cycle Arrest in Neuroblastoma Cells Mol. Cell. Biol., April 1, 2004; 24(7): 2662 - 2672. [Abstract] [Full Text] [PDF]

				K. Beppu, J. Jaboine, M. S. Merchant, C. L. Mackall, and C. J. Thiele Effect of Imatinib Mesylate on Neuroblastoma Tumorigenesis and Vascular Endothelial Growth Factor Expression J Natl Cancer Inst, January 7, 2004; 96(1): 46 - 55. [Abstract] [Full Text] [PDF]